2023 annual financial data
Madrigal Pharmaceuticals 2023 Operating margin
Madrigal Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -380,496,000 USD and net income was -373,630,000 USD.
Operating cash flow was -324,230,000 USD.
Get free Madrigal Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -380,496,000 USD
- Net income
- -373,630,000 USD
- Operating cash flow
- -324,230,000 USD